{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:30:39Z","timestamp":1764052239739,"version":"3.45.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Ovarian reserve depicts the quality and quantity of oocytes remaining in the ovaries and gives an idea about ovarian function at a given time. Because of aging, ovarian reserve diminish physiologically. However, many women face a non-physiologic reduction of ovarian reserve, irrespective of age. To date, standard-of-care treatment options are not available to treat diminished ovarian reserve (DOR). Studies shows that DOR patients mostly undergo\n                      <jats:italic>in vitro<\/jats:italic>\n                      fertilization (IVF) with donor cycles. Hence, identifying effective treatment modalities for DOR is an area of great clinical relevance. This trial will investigate the role of an Ayurvedic treatment protocol in DOR patients prior to IVF. Reports suggest that the factors influencing oocyte maturation can be determined through multi-omics analysis of the follicular fluid. However, the impact of Ayurvedic interventions in improving therapeutic outcomes has yet to be explored in detail. Hence this study also aims to explore whether therapeutic targets can be identified through multi-omics analysis of the follicular fluid collected from the participants after Ayurvedic treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>An open label single arm trial will be conducted to explore the role of an Ayurveda treatment protocol as a prerequisite for IVF in women with DOR. Forty women diagnosed with DOR satisfying eligibility criteria will be recruited to the study. Out of them, thirty participants will be undergoing Ayurveda treatment prior to their next IVF, and ten participants will be assigned to control group for follicular fluid analysis. Within subject change in serum anti-mullerian hormone and antral follicle count will be the primary outcomes evaluated. The multiomics analysis of follicular fluid will be done in 20 participants recruited to the study (treatment group 10 and control group 10).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This multidisciplinary exploratory clinical trial will be the first study to explore the role of an Ayurvedic treatment protocol in managing DOR. The multi-omics approaches will be helpful in identifying potential biomarkers associated with treatment response. The information gained through the study might be useful in planning a safe and feasible pre-conception care for DOR patients undergoing IVF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>ctri.nic.in<\/jats:ext-link>\n                      , identifier CTRI\/2023\/11\/059872.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1666888","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:27:04Z","timestamp":1764052024000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An exploratory single arm study to evaluate the role of an Ayurvedic treatment protocol as a prerequisite for in vitro fertilization in women with diminished ovarian reserve incorporating multi-omics approaches: study protocol"],"prefix":"10.3389","volume":"12","author":[{"given":"Anjaly","family":"Muraleedharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avani","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bipin G.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemavathi Shivapura","family":"Krishnarajabhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chithra","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana","family":"Aji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muralidharan","family":"Vanuopadath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e30320","DOI":"10.7759\/cureus.30320","article-title":"Psychological problems related to infertility","volume":"14","author":"Sharma","year":"2022","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7104a1","article-title":"Assisted reproductive technology surveillance\u2014United States, 2018","volume":"71","author":"Sunderam","year":"2022","journal-title":"MMWR Surveill Summ"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.fertnstert.2022.02.026","article-title":"Managing poor ovarian response in the patient with diminished ovarian reserve","volume":"117","author":"Cedars","year":"2022","journal-title":"Fertil Steril"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.fertnstert.2015.05.017","article-title":"Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System","volume":"104","author":"Devine","year":"2015","journal-title":"Fertil Steril"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3892\/etm.2016.3025","article-title":"Advancement in the treatment of diminished ovarian reserve by traditional Chinese and Western medicine","volume":"11","author":"Zhang","year":"2016","journal-title":"Exp Ther Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.fertnstert.2015.07.1163","article-title":"Can calcium ionophore \u201cuse\u201d in patients with diminished ovarian reserve increase fertilization and pregnancy rates? A randomized, controlled study","volume":"104","author":"Caglar Aytac","year":"2015","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/2045-9912.350862","article-title":"Ozone sauna therapy and pulsed electromagnetic field therapy could potentially improve outcome in women with diminished ovarian reserve undergoing assisted reproductive technology","volume":"13","author":"Dias","year":"2023","journal-title":"Med Gas Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2389469","DOI":"10.1080\/07853890.2024.2389469","article-title":"Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF\/ICSI: a systematic review and meta-analysis","volume":"56","author":"Lin","year":"2024","journal-title":"Ann Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1477-7827-11-44","article-title":"Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis","volume":"11","author":"Narkwichean","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"ref11","volume-title":"Susruta Samhita of Acharya Dalhana","author":"Acharya","year":"2005"},{"key":"ref12","first-page":"366","volume-title":"Ashtanga Hridaya, commentary by Arunadatta and Hemadri, Sarira sthana, Garbhavakranti sarira, 1\/18, edited by Bhishagacharya Harishastri Paradkara Vaidya","author":"Vagbhata","year":"2005"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/ayu.AYU_167_17","article-title":"An ayurvedic treatment protocol to improve anti-mullerian hormone: a prerequisite for assisted reproductive technique\u2014a case report","volume":"38","author":"Muraleedharan","year":"2017","journal-title":"Ayu"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"830691","DOI":"10.3389\/fendo.2021.830691","article-title":"Proteomic analysis of the alterations in follicular fluid proteins during oocyte maturation in humans","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"109453","DOI":"10.1016\/j.abb.2022.109453","article-title":"The follicular fluid metabolome in infertile individuals between polycystic ovary syndrome and diminished ovarian reserve","volume":"732","author":"Shen","year":"2022","journal-title":"Arch Biochem Biophys"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"148979","DOI":"10.1016\/j.gene.2024.148979","article-title":"Downregulation of glucose-energy metabolism via AMPK signaling pathway in granulosa cells of diminished ovarian reserve patients","volume":"933","author":"Zhu","year":"2025","journal-title":"Gene"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12014-020-09286-7","article-title":"Human follicular fluid proteome reveals association between overweight status and oocyte maturation abnormality","volume":"17","author":"Liu","year":"2020","journal-title":"Clin Proteomics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5929694","article-title":"Proteomic analysis of human follicular fluid reveals the pharmacological mechanisms of the Chinese patent drug Kunling pill for improving diminished ovarian reserve","volume":"2022","author":"Wang","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"774667","DOI":"10.3389\/fendo.2021.774667","article-title":"Metabolomic profiling of poor ovarian response identifies potential predictive biomarkers","volume":"12","author":"Song","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/humrep\/deaa279","article-title":"Serum metabolomics study of women with different annual decline rates of anti-mullerian hormone: an untargeted gas chromatography-mass spectrometry-based study","volume":"36","author":"Moslehi","year":"2021","journal-title":"Hum Reprod"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"879974","DOI":"10.3389\/fgene.2022.879974","article-title":"Identification of biomarkers for predicting ovarian Reserve of Primordial Follicle via transcriptomic analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"ref24","first-page":"190","volume-title":"Sujanapriya commentary of Sahasrayogam (Malayalam), Choornayogangal","author":"Krishnan","year":"2009"},{"key":"ref25","first-page":"163","volume-title":"Sujanapriya commentary of Sahasrayogam (Malayalam)","author":"Krishnan","year":"2015"},{"key":"ref26","first-page":"731","volume-title":"Charaka Samhita of Acharya Charaka, Siddhi Sthana. Reprint edition. Ch. 12, Ver. 16","author":"Dutta","year":"2004"},{"key":"ref27","first-page":"366","volume-title":"Ashtanga Hridaya, commentary by Arunadatta and Hemadri, Sarira sthana, Garbhavakranti sarira, 1\/19, edited by Bhishagacharya Harishastri Paradkara Vaidya. Nineth edition","author":"Vagbhata","year":"2005"},{"key":"ref28","first-page":"547","volume-title":"Bhaishajya Ratnavali, Chikita Sthana, 1st edition. Ch. 26, Ver. 325\u2013336","author":"Mishra","year":"2011"},{"key":"ref29","first-page":"184","volume-title":"Vidyotini Hindi Commentary","author":"Samhita","year":"1994"},{"key":"ref30","first-page":"687","volume-title":"Ashtanga Hridaya, Chikitsasthana, Edited by Pt. Hari Sadasiva Shastri Paradakara","author":"Vagbhata","year":""},{"key":"ref31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsmeasuresciau.3c00068","article-title":"Comprehensive overview of bottom-up proteomics using mass spectrometry","volume":"4","author":"Jiang","year":"2024","journal-title":"ACS Meas Sci Au"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizcaino","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Vizcaino","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"Keller","year":"2002","journal-title":"Anal Chem"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"Nesvizhskii","year":"2003","journal-title":"Anal Chem"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3978\/j.issn.2305-5839.2015.04.09","article-title":"Comparison of different stimulation protocols used in in vitro fertilization: a review","volume":"3","author":"Shrestha","year":"2015","journal-title":"Ann Transl Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/acu.2012.0912","article-title":"Diminished ovarian reserve, clomid, and traditional Chinese medicine: a case study","volume":"24","author":"Hullender Rubin","year":"2012","journal-title":"Med Acupunct"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1552581","DOI":"10.3389\/fphar.2025.1552581","article-title":"Clinical efficacy and pharmacological mechanism of Er Zhi Tian Gui formula in enhancing IVF-ET outcomes for diminished ovarian reserve","volume":"16","author":"Chen","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10495-025-02093-1","article-title":"Bushen Jianpi Tiaoxue decoction (BJTD) inhibits the LIF-mTOR signaling axis to regulate mitochondrial function and alleviate cyclophosphamide-induced diminished ovarian reserve","volume":"30","author":"Hu","year":"2025","journal-title":"Apoptosis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13048-025-01632-3","article-title":"Gengnianchun formula ameliorates insulin resistance-induced diminished ovarian reserve via the estrogen signaling pathway: evidence from network pharmacology and experimental validation","volume":"18","author":"Rao","year":"2025","journal-title":"J Ovarian Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/healthcare13111326","article-title":"Integrating acupuncture and herbal medicine into assisted reproductive technology: a systematic review and meta-analysis of east Asian traditional medicine","volume":"13","author":"Peng","year":"2025","journal-title":"Healthcare (Basel, Switzerland)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1666888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:27:11Z","timestamp":1764052031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1666888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":41,"alternative-id":["10.3389\/fmed.2025.1666888"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1666888","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"article-number":"1666888"}}